Pfizer’s Braftovi (encorafenib) regimen has been granted accelerated approval by the US Food and Drug Administration (FDA) to ...

As the world’s third largest pharmaceutical market, Japan accounted for approximately 6% of the $1.5tn in global ...

AstraZeneca’s Tagrisso (osimertinib) has been approved by the European Commission (EC) to treat a new subset of lung cancer ...

As a result, there does seem to be more attention on the patient across med affairs, marketing and communications activity.

If you are struggling to navigate the complexity of early commercialisation, rest assured, you are not alone. Clinical trial ...

Is your medical education strategy reaching the right HCPs in the formats they prefer? Discover actionable insights to ...

Elevate your MedEd strategy with our 2025 toolkit! From AI-driven patient avatars to interactive augmented reality scenarios, ...

Novo Nordisk has announced an investment of 8.5 billion Danish kroner, or approximately $1.2bn, to establish a new rare ...

Gilead Sciences’ seladelpar has been recommended by the European Medicines Agency’s human medicines committee to treat the ...

Presenting your brand strategy for review by your most senior colleagues is a big deal, both professionally and personally.

Technology’s ability to accelerate the pace of innovation while reducing the cost is changing the dynamic of the struggle ...